ODD — Oddity Tech Ltd. stock price, charts and financials

NASDAQ·Consumer Defensive·Household & Personal Products·IL

Latest market price

15.31

+0.08+0.53%

Overview Short InterestFilings

ODDQT30Oddity Tech Ltd.·NASDAQ

Overview Short InterestFilings

15.31+0.53%

News

Up 0.5% — U.S. FDA Grants Orphan Drug Designation to Zai Lab's DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) (gurufocus.com).

Medium confidence

Loading chart...

Screen all →

HELE-2.72%$28.24 EPC+3.41%$28.53 MAGN-0.29%$13.69 HNST+5.99%$3.89 USNA-0.26%$22.78 SPB+2.31%$90.97 COTY+4.30%$2.91 NWL-3.62%$6.13

Snapshot

Index	-	P/E	19.38	EPS (ttm)	0.79	Insider Own	0.39%	Shs Outstand	57.00M	Perf Week	-9.89%

Market Cap	872.63M	Forward P/E	14.99	EPS next Y	1.02	Insider Trans	-62.45%	Shs Float	34.94M	Perf Month	-11.76%

Enterprise Value	1.18B	PEG	0.22	EPS next Q	0.12	Inst Own	-	Short Float	19.51%	Perf Quarter	0.26%

Income	52.00M	P/S	1.18	EPS this Y	-83.97%	Inst Trans	-	Short Ratio	4.20	Perf Half Y	-53.51%

Sales	740.00M	P/B	2.92	EPS next Y	706.12%	ROA	4.91%	Short Interest	6.82M	Perf YTD	-61.90%

Book/sh	5.25	P/C	2.95	EPS next 5Y	87.93%	ROE	14.45%	52W High	75.46 -79.71%	Perf Year	-78.65%

Cash/sh	5.19	P/FCF	-	EPS past 3/5Y	153.88% 97.30%	ROIC	3.98%	52W Low	9.25 65.51%	Perf 3Y	-69.74%

Dividend Est.	-	EV/EBITDA	14.37	Sales past 3/5Y	35.58% 48.81%	Gross Margin	71.09%	Volatility	6.68% 6.06%	Perf 5Y	-

Dividend TTM	-	EV/Sales	1.59	EPS Y/Y TTM	-52.41%	Oper. Margin	6.84%	ATR (14)	1.08	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	2.86	Sales Y/Y TTM	14.37%	Profit Margin	6.97%	RSI (14)	49.61	Recom	2.92

Dividend Gr. 3/5Y	-	Current Ratio	4.06	EPS Q/Q	-124.64%	SMA20	-4.74%	Beta	0.94	Target Price	10.54

Payout	0.00%	Debt/Eq	1.52	Sales Q/Q	-26.12%	SMA50	8.54%	Rel Volume	0.54	Prev Close	15.23

Employees	658	LT Debt/Eq	1.52	Earnings	Sep 09	SMA200	-39.12%	Avg Volume	1.47M	Price	15.31

IPO Date	Jul 19, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	-448.39% 5.36%	Net Debt/EBITDA	4.00	Volume	797,141	Change	0.53%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jun-03-26	Downgrade	Keybanc	Overweight → Sector Weight
Jun-03-26	Reiterated	Barclays	Underweight	$40 → $8.00
Jun-03-26	Downgrade	Goldman Sachs	Neutral → Sell	$16 → $8.00
Jun-03-26	Reiterated	Morgan Stanley	Equal Weight	$49 → $10
Jun-02-26	Reiterated	Jefferies	Hold	$14 → $10
Apr-28-26	Reiterated	Jefferies	Hold	$18 → $14
Mar-27-26	Reiterated	Goldman Sachs	Neutral	$20 → $16
Feb-26-26	Downgrade	Needham	Buy → Hold
Feb-26-26	Downgrade	JP Morgan	Overweight → Neutral
Feb-26-26	Downgrade	Barclays	Equal Weight → Underweight

Latest News

Aug-03-26

Aug-03-2608:00AM

U.S. FDA Grants Orphan Drug Designation to Zai Lab's DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs)gurufocus.com

Jul-22-26

Jul-22-2604:05PM

ODDITY to Announce Second Quarter 2026 Financial Results on September 9, 2026globenewswire.com

Jul-16-26

Jul-16-2607:42AM

Oddity: Hold It Only If You Are Ready To Lose It AllSeekingAlpha

Jul-02-26

Jul-02-2601:00AM

Fosun International Garners Five Awards from Corporate Governance Asiagurufocus.com

Jun-15-26

Jun-15-2606:22AM

Oddity Tech: Recovery Proof Is Still Missing (Rating Downgrade)SeekingAlpha

Jun-12-26

Jun-12-2607:14AM

ODDITY Tech To Repurchase $50M Of 0% Exchangeable Senior Notes Due 2030 For $35MBenzinga

Company

Operating globally, Oddity Tech Ltd. and its affiliated companies function as a consumer technology enterprise. It delivers beauty and wellness merchandise, leveraging its proprietary PowerMatch technology. The firm's strategic focus is on developing and growing digitally native brands, aiming to revolutionize the traditionally brick-and-mortar beauty and wellness sectors. Its product portfolio features items for the face, complexion, eyes, brows, lips, and general skincare, marketed under the IL MAKIAGE label. Additionally, the SpoiledChild brand specializes in hair and skin care solutions. Founded in 2013, this corporation maintains its headquarters in Tel Aviv-Jaffa, Israel.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020
Total Revenue	740	810	647	509	325	223	111
Cost of Goods Sold Incl. D&A	214	221	179	150	106	69	33
Gross Profit	526	589	468	358	218	153	78
Selling, General and Administrative Excl. Other	475	470	353	284	190	134	61
Research and Development	0	0	0	0	0	0	0
Other Operating Expense	0	0	0	0	0	0	0
Operating Income	51	119	116	74	28	20	17
Interest Expense	0	0	0	0	0	1	1
Unusual Expense	—	—	—	—	—	—	—
Non-Operating Income (Expense)	19	17	12	4	1	0	0
Net Income Before Taxes	71	136	128	79	29	19	15
Income Taxes	18	25	26	20	7	5	4
Consolidated Net Income	52	111	101	59	22	14	12
Net Income From Continuing Operations	52	111	101	59	22	14	12
Net Income	52	111	101	59	22	14	12
EPS (Recurring)	0.90	1.95	1.78	1.03	0.11	0.08	0.06
EPS (Basic, Before Extraordinaries)	0.90	1.95	1.78	1.03	0.11	0.08	0.06
EPS (Diluted)	0.79	1.80	1.66	1.00	0.11	0.08	0.06
EBITDA	82	146	138	87	33	24	21
Other After Tax Adjustments	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—
Price To Earnings Ratio	19.38	22.32	25.31	46.53	—	—	—
Price To Sales Ratio	1.16	2.83	3.70	5.21	—	—	—
Gross Margin	71.08	72.72	72.33	70.33	67.08	68.61	70.27
Operating Margin	6.89	14.69	17.93	14.54	8.62	8.97	15.32
Net Margin	7.03	13.70	15.61	11.59	6.77	6.28	10.81
Shares Outstanding	56	57	57	57	57	57	57
Market Capitalization	857	2,290	2,395	2,652	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Drucker Mann Lindsay	Global Chief Financial Officer	Jul 31 '26	Option Exercise	0.00	23,929	0	115,965	Aug 04
Payorski Lilach	Director	Jul 28 '26	Option Exercise	0.00	4,596	0	15,513	Jul 29
Nir Yehoshua	Director	Jul 28 '26	Option Exercise	0.00	4,596	0	8,645	Jul 29
Cheresniya Ohad	Director	Jul 28 '26	Option Exercise	0.00	4,596	0	17,513	Jul 29
Cheresniya Ohad	Director	Jul 19 '26	Option Exercise	0.00	2,956	0	12,917	Jul 20
Drucker Mann Lindsay	Global Chief Financial Officer	Jun 30 '26	Option Exercise	7.58	123,929	939,000	177,709	Jul 01
Drucker Mann Lindsay	Global Chief Financial Officer	Jun 30 '26	Sale	15.09	109,602	1,653,990	77,709	Jul 01
Drucker Mann Lindsay	Global Chief Financial Officer	Jun 01 '26	Sale	13.44	9,603	129,064	77,709	Jun 01
Drucker Mann Lindsay	Global Chief Financial Officer	May 31 '26	Option Exercise	0.00	23,929	0	87,312	Jun 01
Drucker Mann Lindsay	Global Chief Financial Officer	Apr 30 '26	Option Exercise	0.00	23,929	0	72,983	May 01
Drucker Mann Lindsay	Global Chief Financial Officer	Apr 30 '26	Sale	15.62	9,600	149,952	63,383	May 01
Drucker Mann Lindsay	Global Chief Financial Officer	Mar 31 '26	Option Exercise	0.00	23,929	0	58,658	Apr 01
Drucker Mann Lindsay	Global Chief Financial Officer	Mar 31 '26	Sale	12.85	9,604	123,411	49,054	Apr 01

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.